Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov;26(11):105831.
doi: 10.1016/j.jamda.2025.105831. Epub 2025 Sep 11.

Smart Glasses for Older Adults With Cognitive Impairment: A Scoping Review

Affiliations

Smart Glasses for Older Adults With Cognitive Impairment: A Scoping Review

Brittany F Burch et al. J Am Med Dir Assoc. 2025 Nov.

Abstract

Objectives: This study aimed to identify and synthesize peer-reviewed literature on smart glasses for older adults with cognitive impairment. The review focused on (1) the technology and equipment used, (2) the specific tasks smart glasses are designed to support, (3) feasibility outcomes, when measured, and (4) the quality of the reviewed articles.

Design: Scoping review.

Setting and participants: Older adults with cognitive impairment.

Methods: A research librarian conducted a comprehensive search across 8 databases to identify peer-reviewed studies that investigated the use of smart glasses for older adults with cognitive impairment. Two authors independently used Covidence to review articles for extraction and organization.

Results: Our search yielded 414 articles and 13 were included for data extraction and appraisal. All included studies were rated as low quality. Seven studies focused on commercially available smart glasses and 6 focused on early-stage prototypes of smart glasses. Only 5 studies involved hands-on testing with older adults, and just one study exclusively involved participants with cognitive impairment. The main purpose of the smart glasses included assisting older adults with daily tasks, recognizing faces, aiding in navigation, and helping care partners locate or monitor individuals with cognitive impairment.

Conclusions and implications: More rigorous studies are needed to test smart glasses among older adults with cognitive impairment and the literature does not reflect the recent advancements in smart glasses technology. Future smart glasses research should include more interdisciplinary teams, utilize user-centered design frameworks, and obtain long-term feasibility and effectiveness data among larger samples of older adults with cognitive impairment.

Keywords: Smart glasses; cognitive impairment; dementia; older adults; technology.

PubMed Disclaimer

Conflict of interest statement

Disclosure

The authors declare no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
The PRISMA Flow Diagram describes the article screening process. The search generated 414 articles, 137 of which were duplicates and subsequently removed. We removed 244 articles during the title and abstract screening and we removed an additional 23 articles during the full-text screening, resulting in 10 articles remaining. On reviewing the reference lists of the 10 remaining articles, 3 additional articles were included, resulting in a total of 13 articles for this review. VR/AR, virtual reality/augmented reality.

References

    1. Pais R, Ruano L, Carvalho OP, Barros H. Global cognitive impairment prevalence and incidence in community dwelling older adults—A systematic review. Geriatrics. 2020;5:1–16. - PMC - PubMed
    1. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry. 2001;16:751–761. - PubMed
    1. Kuring JK, Mathias JL, Ward L. Prevalence of depression, anxiety and PTSD in people with dementia: a systematic review and meta-analysis. Neuropsychol Rev. 2018;28:393–416. - PubMed
    1. Buckley JS, Salpeter SR. A risk-benefit assessment of dementia medications: systematic review of the evidence. Drugs Aging. 2015;32:453–467. - PubMed
    1. Qiao Y, Chi Y, Zhang Q, Ma Y. Safety and efficacy of lecanemab for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. Front Aging Neurosci. 2023;15:1169499. - PMC - PubMed

Publication types